Schedule 13D ownership disclosure

Carbylan Therapeutics, Inc.

Security class unavailable · CUSIP: 141384107

Event date: 2016-02-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
31,146,032
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-16-097511
Form type
SC 13D
Filer
BFAM Partners (Cayman) Ltd
CIK
CIK 1639101
Filed
Feb 17, 2016
Reporting period
Feb 04, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub